Neurology News

Following an intracerebral hemorrhage, decreased estimated glomerular filtration rate correlated with poor outcomes, according to study results published in Neurology.

The FDA granted orphan drug designation to ALS001, an autologous, expanded T-cell therapy under development by Coya Therapeutics for treating ALS, according to a press release.

The FDA has said that Johnson & Johnson’s COVID-19 vaccine may lead to an increased risk for Guillain-Barré syndrome.

An updated position statement issued by the American Academy of Neurology about ethical considerations that often arise in the treatment of patients with dementia revises the organization’s statement from 1996 on the same topic.

Despite the increasing number of women entering academic internal medicine, researchers found that “substantial salary inequities persist at the highest faculty levels and specifically in procedural-based specialties.”

Patients with large vessel occlusion stroke undergoing endovascular thrombectomy who were transferred directly to the angiography suite at admission had faster treatment and better functional outcomes during all hours and treatment windows.

At hospitals participating in Get With the Guidelines-Stroke, patients with acute ischemic stroke received similar quality care and had comparable outcomes before and during the COVID-19 pandemic.

Long-term results from the ASCOT trial demonstrated that an amlodipine-based BP-lowering regimen reduced stroke risk compared with an atenolol-based regimen, although no benefit in dementia risk was observed.

The FDA called for a federal investigation into the approval of Aduhelm for the treatment of patients with Alzheimer’s disease, as reported by STAT.

Diabetes correlated with decreased cognition through neurodegeneration, regardless of small vessel disease and Alzheimer’s disease biomarkers, according to a cross-sectional analysis of MEMENTO, a large clinical cohort study.